197 related articles for article (PubMed ID: 2435886)
1. Biphasic release of endothelium-derived relaxing factor(s) by acetylcholine from perfused canine femoral arteries. Characterization of muscarinic receptors.
Rubanyi GM; McKinney M; Vanhoutte PM
J Pharmacol Exp Ther; 1987 Mar; 240(3):802-8. PubMed ID: 2435886
[TBL] [Abstract][Full Text] [Related]
2. Phorbol dibutyrate inhibits release and action of endothelium-derived relaxing factor(s) in canine blood vessels.
Rubanyi GM; Desiderio D; Luisi A; Johns A; Sybertz EJ
J Pharmacol Exp Ther; 1989 Jun; 249(3):858-63. PubMed ID: 2499677
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective effect of diltiazem on endothelium-dependent relaxations in canine femoral arteries.
Rubanyi GM; Hoeffner U; Schwartz A; Vanhoutte PM
J Pharmacol Exp Ther; 1988 Jul; 246(1):60-4. PubMed ID: 2455796
[TBL] [Abstract][Full Text] [Related]
4. Anisodamine inhibits acetylcholine-induced endothelium-dependent relaxation of canine femoral artery.
Guo HY; Loren RR; Vanhutte PM
Chin Med J (Engl); 1992 Aug; 105(8):666-70. PubMed ID: 1458970
[TBL] [Abstract][Full Text] [Related]
5. Vascular actions of TA 3090, a novel analog of diltiazem: interaction with endothelium-dependent relaxation in canine femoral and coronary arteries.
Rubanyi G; Iqbal A; Schwartz A; Vanhoutte PM
J Pharmacol Exp Ther; 1991 Nov; 259(2):639-42. PubMed ID: 1941612
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of endothelium-dependent responses to acetylcholine in canine femoral arteries and veins. Separation of the role played by endothelial and smooth muscle cells.
Rubanyi GM; Vanhoutte PM
Blood Vessels; 1988; 25(2):75-81. PubMed ID: 3257889
[TBL] [Abstract][Full Text] [Related]
7. Acetylcholine stimulates release of endothelium-derived relaxing factor in coronary arteries of human organ donors.
Blaise GA; Stewart DJ; Guérard MJ
Can J Cardiol; 1993 Nov; 9(9):813-20. PubMed ID: 8281481
[TBL] [Abstract][Full Text] [Related]
8. Presynaptic M2-muscarinic receptors on noradrenergic nerve endings and endothelium-derived M3 receptors in cat cerebral arteries.
Alonso MJ; Arribas S; Marín J; Balfagón G; Salaices M
Brain Res; 1991 Dec; 567(1):76-82. PubMed ID: 1726141
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of endothelium-dependent relaxations by phorbol myristate acetate in canine coronary arteries: role of a pertussis toxin-sensitive G-protein.
Flavahan NA; Shimokawa H; Vanhoutte PM
J Pharmacol Exp Ther; 1991 Jan; 256(1):50-5. PubMed ID: 1899121
[TBL] [Abstract][Full Text] [Related]
10. Pertussis toxin reduces endothelium-dependent and independent responses to alpha-2- adrenergic stimulation in systemic canine arteries and veins.
Miller VM; Flavahan NA; Vanhoutte PM
J Pharmacol Exp Ther; 1991 Apr; 257(1):290-3. PubMed ID: 1850467
[TBL] [Abstract][Full Text] [Related]
11. Augmented endothelium-derived hyperpolarizing factor-mediated relaxations attenuate endothelial dysfunction in femoral and mesenteric, but not in carotid arteries from type I diabetic rats.
Shi Y; Ku DD; Man RY; Vanhoutte PM
J Pharmacol Exp Ther; 2006 Jul; 318(1):276-81. PubMed ID: 16565165
[TBL] [Abstract][Full Text] [Related]
12. Ouabain inhibits endothelium-dependent relaxations to arachidonic acid in canine coronary arteries.
Rubanyi GM; Vanhoutte PM
J Pharmacol Exp Ther; 1985 Oct; 235(1):81-6. PubMed ID: 3930700
[TBL] [Abstract][Full Text] [Related]
13. 15-lipoxygenase metabolites of arachidonic acid evoke contractions and relaxations in isolated canine arteries: role of thromboxane receptors, endothelial cells and cyclooxygenase.
Van Diest MJ; Verbeuren TJ; Herman AG
J Pharmacol Exp Ther; 1991 Jan; 256(1):194-203. PubMed ID: 1824864
[TBL] [Abstract][Full Text] [Related]
14. Endothelium-dependent inhibitory effects of acetylcholine, adenosine triphosphate, thrombin and arachidonic acid in the canine femoral artery.
De Mey JG; Claeys M; Vanhoutte PM
J Pharmacol Exp Ther; 1982 Jul; 222(1):166-73. PubMed ID: 6806467
[TBL] [Abstract][Full Text] [Related]
15. Sex differences in the relative contributions of nitric oxide and EDHF to agonist-stimulated endothelium-dependent relaxations in the rat isolated mesenteric arterial bed.
McCulloch AI; Randall MD
Br J Pharmacol; 1998 Apr; 123(8):1700-6. PubMed ID: 9605578
[TBL] [Abstract][Full Text] [Related]
16. Endothelium-dependent effects of carteolol.
Janczewski P; Boulanger C; Iqbal A; Vanhoutte PM
J Pharmacol Exp Ther; 1988 Nov; 247(2):590-5. PubMed ID: 2903235
[TBL] [Abstract][Full Text] [Related]
17. Oxytocin causes endothelium-dependent relaxations of canine basilar arteries by activating V1-vasopressinergic receptors.
Katusic ZS; Shepherd JT; Vanhoutte PM
J Pharmacol Exp Ther; 1986 Jan; 236(1):166-70. PubMed ID: 3001282
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of acyl-coenzyme A:lysolecithin acyltransferase activate the production of endothelium-derived vascular relaxing factor.
Förstermann U; Goppelt-Strübe M; Frölich JC; Busse R
J Pharmacol Exp Ther; 1986 Jul; 238(1):352-9. PubMed ID: 3487639
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms underlying endothelium-independent relaxation by acetylcholine in canine retinal and cerebral arteries.
Toda N; Zhang JX; Ayajiki K; Okamura T
J Pharmacol Exp Ther; 1995 Sep; 274(3):1507-12. PubMed ID: 7562527
[TBL] [Abstract][Full Text] [Related]
20. Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase.
Gil DW; Wolfe BB
J Pharmacol Exp Ther; 1985 Mar; 232(3):608-16. PubMed ID: 2579230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
